FDA's Flexibility in Subpart H Approvals: Assessing Quantum of Effectiveness Evidence
{{output}}
This article examines the strength of scientific and clinical evidence for FDA's nineteen non-AIDS, non-cancer Subpart H approval determinations over the Accelerated Approval program's twenty-four year existence. The authors researched the bases for FDA's dete... ...
